globalKobicTop_logo
KEGG : Amyotrophic lateral sclerosis (ALS)

Pathway Class : Human Diseases; Neurodegenerative Diseases
Pathway Description : Amyotrophic lateral sclerosis (ALS) is a progressive, lethal, degenerative disorder of motor neurons. The hallmark of this disease is the selective death of motor neurons in the brain and spinal cord, leading to paralysis of voluntary muscles. Mutant superoxide dismutase 1 (SOD1), as seen in some familial ALS (FALS) cases, is unstable, forming aggregates in the motor neuron cytoplasm, axoplasm and mitochondria. Within mitochondria, mutant SOD1 may interfere with the anti-apoptotic function of Bcl-2, affect mitochondrial import by interfering with the translocation machinery (TOM/TIM), and generate toxic free radicals (ROS). Reactive oxygen species (ROS), produced within mitochondria, inhibit the function of EAAT2, the main glial glutamate transporter protein, responsible for most of the reuptake of synaptically released glutamate. Glutamate excess increases intracellular calcium, which enhances oxidative stress and mitochondrial damage. Mutant SOD1 can also trigger oxidative reactions , which can then cause damage through the formation of hydroxyl radicals or via nitration of tyrosine residues on proteins. Nitration may target neurofilament proteins, affecting axonal transport. Collectively, these mechanisms are predicted to disturb cellular homeostasis, ultimately triggering motor neuron death.(obtained from KEGG 10/09/11)

Legend
1)Visualization

2)Reference List
Reference ID Source
16924260Pubmed
16723044Pubmed
17015226Pubmed
11239414Pubmed
16050975Pubmed
11870681Pubmed
16713195Pubmed
16026864Pubmed
10970056Pubmed
12531867Pubmed
16909017Pubmed
14739060Pubmed
11715057Pubmed
15310460Pubmed
12595144Pubmed
16603792Pubmed
18519638Pubmed
14569202Pubmed
12728264Pubmed
11513882Pubmed
17434459Pubmed
16909020Pubmed
17566607Pubmed
17409386Pubmed